Lemmon Christopher A相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial

阿米万单抗治疗复发性或转移性腺样囊性癌：一项 II 期非随机临床试验

期刊:Jama Otolaryngology-Head & Neck Surgery

影响因子:5.6

doi:10.1001/jamaoto.2025.5404

Hanna, Glenn J; Zamulko, Olga Y; Grover, Punita; Adkins, Douglas R; Oppelt, Peter J; Romano, Audrey E; Lehn, Maria A; Bachmann, Lindsey M; Wikenheiser-Brokamp, Kathryn A; Lemmon, Christopher A; Forsythe, Allison J; Allen, Casey L; Pan, Jianmin; Rai, Shesh N; El-Gamal, Dalia; Wise-Draper, Trisha M

免疫/内分泌

发表日期：2026

文献求助收藏

Measuring the biomechanical properties of cell-derived fibronectin fibrils

测量细胞衍生纤连蛋白原纤维的生物力学特性

期刊:Biomechanics and Modeling in Mechanobiology

影响因子:2.7

doi:10.1007/s10237-024-01918-3

Dalton, Caleb J; Dhakal, Soma; Lemmon, Christopher A

细胞生物学

发表日期：2025

文献求助收藏

Fibrotic extracellular matrix preferentially induces a partial Epithelial-Mesenchymal Transition phenotype in a 3-D agent based model of fibrosis

在基于三维纤维化模型的细胞外基质中，纤维化细胞外基质优先诱导部分上皮-间质转化表型。

期刊:Mathematical Biosciences

影响因子:1.8

doi:10.1016/j.mbs.2025.109375

Kim, Kristin P; Lemmon, Christopher A

细胞生物学

发表日期：2025

文献求助收藏

Modeling Costs and Life-Years Gained by Population-Wide Next-Generation Sequencing or Single-Gene Testing in Nonsquamous Non-Small-Cell Lung Cancer in the United States

美国非鳞状非小细胞肺癌人群中，通过全人群下一代测序或单基因检测来模拟成本和预期寿命延长

期刊:Jco Precision Oncology

影响因子:5.6

doi:10.1200/PO.22.00294

Lemmon, Christopher A; Zhou, Jie; Hobbs, Brian; Pennell, Nathan A

细胞生物学

发表日期：2023

文献求助收藏

Spatial Gradients of E-Cadherin and Fibronectin in TGF-β1-Treated Epithelial Colonies Are Independent of Fibronectin Fibril Assembly

TGF-β1处理的上皮细胞集落中E-钙黏蛋白和纤连蛋白的空间梯度与纤连蛋白原纤维组装无关

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms24076679

Griggs, Lauren A; Lemmon, Christopher A

细胞生物学

发表日期：2023

文献求助收藏

Modeling the Cost-Effectiveness of Adjuvant Osimertinib for Patients with Resected EGFR-mutant Non-Small Cell Lung Cancer

对接受手术切除的EGFR突变型非小细胞肺癌患者进行辅助奥希替尼治疗的成本效益建模

期刊:Oncologist

影响因子:4.2

doi:10.1093/oncolo/oyac021

Lemmon, Christopher A; Zabor, Emily C; Pennell, Nathan A

细胞生物学

发表日期：2022

文献求助收藏

A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC

一项针对可切除的IIIA期非小细胞肺癌患者的I期研究，评估新辅助帕博利珠单抗联合放化疗后序贯帕博利珠单抗巩固治疗的疗效。

期刊:JTO Clinical and Research Reports

影响因子:3.5

doi:10.1016/j.jtocrr.2022.100359

Lemmon, Christopher A; Videtic, Gregory M M; Murthy, Sudish; Stephans, Kevin L; Shapiro, Marc; Ahmad, Usman; Raymond, Daniel; Velcheti, Vamsidhar; Bribriesco, Alejandro; Jia, Xuefei; Stevenson, James; Pennell, Nathan A

细胞生物学

发表日期：2022

文献求助收藏

A data-assimilation approach to predict population dynamics during epithelial-mesenchymal transition

一种利用数据同化方法预测上皮-间质转化过程中种群动态的方法

期刊:Biophysical Journal

影响因子:3.1

doi:10.1016/j.bpj.2022.07.014

Mendez, Mario J; Hoffman, Matthew J; Cherry, Elizabeth M; Lemmon, Christopher A; Weinberg, Seth H

发表日期：2022

文献求助收藏

Cell-Matrix Interactions in Renal Fibrosis

肾纤维化中的细胞-基质相互作用

doi:10.3390/kidneydial2040055

Kim, Kristin P; Williams, Caitlin E; Lemmon, Christopher A

细胞生物学

发表日期：2022

文献求助收藏

Fibronectin: Molecular Structure, Fibrillar Structure and Mechanochemical Signaling

纤连蛋白：分子结构、纤维结构和机械化学信号传导

影响因子:5.2

doi:10.3390/cells10092443

Dalton, Caleb J; Lemmon, Christopher A

发表日期：2021

文献求助收藏